phase readout
saveNCT07303322: Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of N1087 in Participants With Female Pattern Hair Loss (MINORA-WOMEN)
NOT_YET_RECRUITINGupdated 11d ago
community read0 votes
Sponsor: Eurofarma Laboratorios S.A.. Phase: PHASE3. Conditions: Female Pattern Hair Loss, Female Pattern Hair Loss, Androgenic Alopecia
view source ↗
comments(0)
5-min edit window · permanent after that